Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,260
Total Claims
$1.3M
Drug Cost
751
Beneficiaries
$1,759
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-50%
Opioid rate vs peers
1.1% vs 2.2% avg
+25%
Cost per patient vs peers
$1,759 vs $1,411 avg
+42%
Brand preference vs peers
15.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.1%
Opioid Rate
104
Opioid Claims
$1,479
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,386 claims · $1.1M
Generic: 7,800 claims · $261K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 152 | $100K |
| Dapagliflozin Propanediol | 70 | $80K |
| Rivaroxaban | 68 | $74K |
| Insulin Glargine/Lixisenatide | 53 | $47K |
| Empagliflozin/Metformin Hcl | 48 | $46K |
| Semaglutide | 30 | $39K |
| Sitagliptin Phosphate | 23 | $35K |
| Dapaglifloz Propaned/Metformin | 22 | $30K |
| Semaglutide | 27 | $26K |
| Dulaglutide | 18 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $21K |
| Fluticasone/Umeclidin/Vilanter | 21 | $20K |
| Linaclotide | 36 | $19K |
| Empagliflozin | 11 | $18K |
| Atorvastatin Calcium | 801 | $16K |
Prescribing Profile
Patient Profile
75
Avg Age
57%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About